← Open Payments lookup

JEREMY RINALDI: Open Payments

NPI 1114574159 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,066 in 56 payments from 12 companies in 2025. Trend: 2023 $320 · 2024 $824 · 2025 $1,066

Food & beverage: $977Education: $89
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.11$247
GlaxoSmithKline, LLC.18$191
BioCryst US Sales Co., LLC8$183
ARS Pharmaceuticals Operations, Inc.4$96
Ionis Pharmaceuticals, Inc.3$70
Novartis Pharmaceuticals Corporation3$64
Genentech USA, Inc.2$59
AstraZeneca Pharmaceuticals LP2$48
ALK-Abello, Inc2$47
CSL Behring1$23

Products named: DUPIXENT, ORLADEYO, NUCALA, NEFFY, TRELEGY ELLIPTA, Xolair, TEZSPIRE, Odactra.

Industry payments across CA — which companies pay providers there.